Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization
- 1 July 2005
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 98 (1), 24-30
- https://doi.org/10.1016/j.ygyno.2005.03.041
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Role of HER receptors family in development and differentiationJournal of Cellular Physiology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Uterine papillary serous carcinoma (UPSC): a single institution review of 129 casesGynecologic Oncology, 2003
- Endometrial Papillary Serous Carcinoma: Patterns of Spread and TreatmentClinical Obstetrics and Gynecology, 1996
- Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA contentCancer, 1994
- Uterine Papillary Serous Carcinoma: Patterns of Metastatic SpreadGynecologic Oncology, 1994
- Expression of EGFR, HER-2/neu, P53, and PCNA in Endometrioid, Serous Papillary, and Clear Cell Endometrial AdenocarcinomasGynecologic Oncology, 1994
- HER-2/neu expression: A major prognostic factor in endometrial cancerGynecologic Oncology, 1992
- Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage diseaseAmerican Journal of Obstetrics and Gynecology, 1991
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982